MW

Milind Wasalwar Laxamanrao

Active Director Director DIN 07687287
DIN 07687287 First appointment Feb 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Milind Wasalwar Laxamanrao

Data last updated:

Milind Wasalwar Laxamanrao is a Director at Subal Pharmaceuticals Private Limited (since 2017). The company operates in Pharma.

DIN 07687287
Primary Designation Director
Industry Pharma
First Appointment 08 Feb 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Feb 20172017Active

Board colleagues of Milind Wasalwar Laxamanrao

NameDINCompanyDesignation
Rajasri Milind Wasalwar09687154Subal Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Subal Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Milind Wasalwar Laxamanrao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Milind Wasalwar Laxamanrao

Milind Wasalwar Laxamanrao currently holds 1 directorship: Subal Pharmaceuticals Private Limited (Director, since 08 Feb 2017).

Milind Wasalwar Laxamanrao was first appointed on 08 Feb 2017 as Director at Subal Pharmaceuticals Private Limited.

The current boards of Milind Wasalwar Laxamanrao's companies include Rajasri Milind Wasalwar (Subal Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available